Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
20 earlier
Referred to the House Committee on the Judiciary.
Original title: “HR 8779: To prohibit pharmacy benefit managers and pharmacies from being under common ownership, and for other purposes.”
Referred to the Committee on the Judiciary. (text: CR S2281-2282)
Original title: “SRES 727: A resolution supporting the designation of May 29, 2026, as "Mental Health Awareness in Agriculture Day" to raise awareness around mental health in the agricultural industry and workforce and to continue to reduce stigma associated with mental illness.”
Motion to proceed to consideration of measure rejected in Senate by Yea-Nay Vote. 50 - 50. Record Vote Number: 122.
Original title: “SJRES 141: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".”
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Original title: “S 3989: A bill to amend the Public Health Service Act to provide community-based training opportunities for medical students in rural areas and medically underserved communities, and for other purposes.”
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S292)
Original title: “S 3697: A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.”
Committee on Veterans' Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.
Original title: “S 3138: A bill to amend title 38, United States Code, to include adaptive prostheses and terminal devices for sports and other recreational activities in the medical services furnished to eligible veterans by the Secretary of Veterans Affairs.”
Committee on Health, Education, Labor, and Pensions. Hearings held.
Original title: “S 2531: A bill to authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes.”
Read twice and referred to the Committee on Veterans' Affairs.
Original title: “S 2096: A bill to amend titles 10 and 38, United States Code, to make certain improvements in the Transition Assistance Program and Solid Start Program to address mental health issues, and for other purposes.”
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Original title: “S 1330: A bill to advance research to achieve medical breakthroughs in brain tumor treatment and improve awareness and adequacy of specialized cancer and brain tumor care.”
Referred to the House Committee on Energy and Commerce.
Original title: “HR 8807: Maternal Health Pandemic Response Act”
The Administration for Children and Families (ACF) is requesting a 3-year extension of the Guidance for the Tribal Temporary Assistance for Needy Families (TANF) Program, Form 123 (Office of Management and Budget 0970-0157, expiration date: August 31, 2026). While the statutory requirements remain unchanged, ACF is proposing revisions to the instructions for clarification and to ensure they are as clear and streamlined as possible. ACF estimates a 33 percent reduction in response time with the p
Original title: “Proposed Information Collection Activity; Guidance for Tribal Temporary Assistance for Needy Families (TANF) Program, ACF-123”
The Office of Community Services (OCS), Administration for Children and Families (ACF) requests approval of the Community Services Block Grant (CSBG) Disaster Supplemental Annual Report. This is a new information collection request, based on a previously approved version of this report under Office of Management and Budget (OMB) #: 0970- 0492. This covers CSBG Disaster Supplemental Funds as appropriated by the Robert T. Stafford Disaster Relief and Emergency Assistance Act and potential future d
Original title: “Proposed Information Collection Activity; Community Services Block Grant Disaster Supplemental Annual Report (New Collection)”
Read twice and referred to the Committee on Appropriations. (text: CR S2239)
Original title: “S 4494: A bill to prioritize funding for an expanded and sustained national investment in biomedical research.”
Referred to the House Committee on Veterans' Affairs.
Original title: “HR 6710: Fiscal Year 2025 Veterans Affairs Major Medical Facility Authorization Act”
Held at the desk.
Original title: “S 2393: Fiscal Year 2025 Veterans Affairs Major Medical Facility Authorization Act”
Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.
Original title: “FDA’s leadership void leaves biotech with renewed ‘uncertainty’”
With Commissioner Marty Makary’s exit, the FDA will enter a period of “unprecedented” and “prolonged” leadership vacuum, analysts at Capital Alpha predicted, noting that the government will have trouble finding someone who will want to take the FDA’s reins.
Original title: “After ‘most damaging period in FDA history,’ Makary will be hard to replace”
Belfast base will expand regulatory support, boost innovation and deepen engagement
Original title: “MHRA to open new Northern Ireland hub to strengthen UK‑wide life sciences collaboration”